News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,056 Results
Type
Article (1217)
Company Profile (7)
Press Release (40832)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (17750)
Career Advice (49)
Deals (2489)
Drug Delivery (5)
Drug Development (5209)
Employer Resources (5)
FDA (956)
Job Trends (1198)
News (24321)
Policy (1396)
Tag
2027 Bio NC Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (81)
Accelerated approval (9)
ADA (4)
Adcomms (1)
Allergies (20)
Alliances (1565)
ALS (14)
Alzheimer's disease (87)
Antibody-drug conjugate (ADC) (66)
Approvals (1075)
Artificial intelligence (27)
ASCO (43)
Autoimmune disease (34)
Automation (3)
Bankruptcy (11)
Belgium (1)
Best Places to Work (1135)
BIO (2)
Biologics (1)
Biosimilars (14)
BioSpace Insights (4)
Biotechnology (8)
Bladder cancer (22)
Brain cancer (7)
Breast cancer (118)
Cancer (725)
Cardiovascular disease (58)
Career advice (43)
CAR-T (13)
CDC (2)
CDMO (3)
Cell therapy (46)
Cervical cancer (7)
Clinical research (5419)
Collaboration (98)
Compensation (55)
Complete response letters (5)
COVID-19 (99)
CRISPR (3)
C-suite (43)
Cystic fibrosis (7)
Data (1038)
Denatured (2)
Depression (12)
Dermatology (22)
Diabetes (60)
Diagnostics (495)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (23)
Drug pricing (6)
Duchenne muscular dystrophy (15)
Earnings (16111)
Editorial (1)
Employer resources (4)
Events (3878)
Executive appointments (39)
Eye disease (1)
FDA (1475)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (105)
Gene editing (8)
Generative AI (4)
Gene therapy (36)
GLP-1 (90)
Government (147)
Grass and pollen (2)
Guidances (172)
Healthcare (1107)
Hematology (14)
HIV (7)
Huntington's disease (6)
IgA nephropathy (19)
Immunology and inflammation (26)
Immuno-oncology (6)
Indications (30)
Infectious disease (128)
Inflammatory bowel disease (10)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (15)
Interviews (6)
IPO (1771)
IRA (1)
Job creations (120)
Job search strategy (38)
Kidney cancer (5)
Kidney disease (8)
Labor market (9)
Layoffs (25)
Leadership (1)
Legal (177)
Licensing (5)
Liver cancer (11)
Longevity (1)
Lung cancer (115)
Lymphoma (70)
Machine learning (4)
Manufacturing (71)
MASH (26)
Medical device (998)
Medtech (1014)
Mergers & acquisitions (821)
Metabolic disorders (147)
mRNA (5)
Multiple sclerosis (29)
NASH (2)
Neurodegenerative disease (19)
Neuropsychiatric disorders (8)
Neuroscience (214)
NextGen: Class of 2026 (232)
Non-profit (132)
Now hiring (4)
Obesity (64)
Opinion (5)
Ovarian cancer (16)
Pain (21)
Pancreatic cancer (53)
Parkinson's disease (18)
Partnered (3)
Patents (28)
Patient recruitment (43)
Patient selection (1)
Peanut (9)
People (1357)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (1097)
Phase 2 (2156)
Phase 3 (2369)
Pipeline (1842)
Policy (3)
Postmarket research (266)
Preclinical (347)
Prostate cancer (41)
Psychedelics (2)
Radiopharmaceuticals (35)
Rare diseases (72)
Real estate (189)
Regulatory (1543)
Reports (7)
Research institute (87)
Resumes & cover letters (1)
Rett syndrome (2)
RNA editing (1)
RSV (6)
Schizophrenia (13)
Series A (8)
Series B (13)
Service/supplier (1)
Sickle cell disease (5)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (80)
Stomach cancer (3)
Supply chain (7)
Tariffs (5)
The Weekly (3)
Vaccines (64)
Venture capital (6)
Weight loss (33)
Wet AMD (1)
Women's health (8)
Worklife (3)
Date
Today (13)
Last 7 days (50)
Last 30 days (159)
Last 365 days (2790)
2026 (2063)
2025 (2953)
2024 (3047)
2023 (3201)
2022 (3488)
2021 (3700)
2020 (3266)
2019 (2757)
2018 (2073)
2017 (1999)
2016 (1285)
2015 (1792)
2014 (1227)
2013 (879)
2012 (1070)
2011 (1075)
2010 (928)
Location
Africa (37)
Alabama (5)
Arizona (17)
Asia (3341)
Australia (3327)
California (1336)
Canada (443)
China (158)
Colorado (64)
Connecticut (51)
Delaware (56)
Europe (6350)
Florida (148)
Georgia (44)
Idaho (4)
Illinois (91)
India (6)
Indiana (70)
Japan (59)
Kansas (4)
Kentucky (6)
Louisiana (11)
Maine (3)
Maryland (151)
Massachusetts (745)
Michigan (31)
Minnesota (107)
Mississippi (1)
Missouri (50)
Montana (5)
Nevada (6)
New Hampshire (6)
New Jersey (478)
New York (337)
North Carolina (143)
Northern California (835)
Ohio (32)
Oregon (1)
Pennsylvania (451)
Rhode Island (1)
South America (62)
South Carolina (3)
Southern California (431)
Tennessee (22)
Texas (154)
United States (4696)
Utah (45)
Virginia (18)
Washington D.C. (1)
Washington State (123)
West Virginia (1)
Wisconsin (13)
42,056 Results for "61".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
September 15, 2026
·
4 min read
Press Releases
Greenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy
August 7, 2026
·
3 min read
Press Releases
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
August 13, 2026
·
23 min read
Press Releases
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
March 13, 2026
·
4 min read
Press Releases
Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
January 12, 2026
·
5 min read
Press Releases
Nocturia Market Poised for Rapid Growth, Expected to Reach USD 7.61 Billion by 2032 | Coherent Market Insights
January 20, 2026
·
1 min read
Press Releases
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
May 5, 2026
·
4 min read
Epigenetics Market Size Forested to be Worth over USD 61.04 Bn by 2033
According to the Vision Research Reports, the global epigenetics market size was estimated at around USD 14.65 billion in 2023 and it is forecasted to be worth over USD 61.04 billion by 2033 with a CAGR of 15.34% from 2024 to 2033
April 23, 2024
·
20 min read
Cancer Biomarkers Market Size to Worth Around USD 61.37 Billion by 2033 | CAGR 14.62%
According to Vision Research Reports, the global cancer biomarkers market size was accounted for USD 15.68 billion in 2023 and it is increasing around USD 61.37 billion by 2033 with a CAGR of 14.62% from 2024 to 2033.
April 15, 2024
·
15 min read
Press Releases
Ultomiris Drug Market Size to Hit USD 48.61 Billion by 2034, Growing at a Stellar 28.5% CAGR
November 24, 2025
·
1 min read
1 of 4,206
Next
